Delivery Order SPE2DB22D1041-SPE2DB24FUAH8

Award Date 3/18/24
Potential Completion Date 3/19/24
Potential Value $2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $7,657.81 order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. No set-aside designation was used. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the leading global pharmaceutical sourcing and distribution company AmerisourceBergen Corporation. The order, valued at $5,453.78, is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a specialty brand name pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp with a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $5,383.98 order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S and does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, regularly provides pharmaceuticals and medical supplies to DLA Troop Support Medical to support military treatment programs and facilities. This...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Trelegy Ellipta (100-62.5-25) inhalation product. The order is valued at $3,922.33 and has an ultimate completion date of September 6, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a $48,416.84 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The delivery order is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s. The order has an ultimate completion date of April 12, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,232.63 firm-fixed-price contract is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60s, with an ultimate completion date of October 27, 2023. The contract is not designated with a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a division of the global pharmaceutical distributor Amerisourcebergen Corporation. The $2,420.16 order is for TRELEGY ELLIPTA 100-62.5-25 60S, a specialty pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value up to $999,999,999.00 and a performance period through...
This is a firm fixed price delivery order awarded by the Medical Supply Chain, a division of the Defense Logistics Agency (DLA), to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The order is for the pharmaceutical product Trelegy Ellipta 200-62.5-25 60S, with a ceiling value of $10,516.42 and a completion date of June 1, 2022. AmerisourceBergen Drug Corp holds an indefinite delivery contract with DLA Troop Support Medical with a potential value of...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $3,211.80 order is for the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. No set-aside designation was used for this award. AmerisourceBergen Drug Corp serves as a prime contractor providing a wide range of pharmaceutical products and medical supplies to the Department of Defense through DLA Troop Support Medical....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The $16,651.73 firm fixed-price contract is for the delivery of the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. This award is associated with a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
  • SPE2DB22D1041
    Indefinite Delivery Contract
  • SPE2DB22D1041-SPE2DB24FUAH8
    Delivery Order

This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of the global pharmaceutical company AmerisourceBergen Corporation. The $1,950.68 order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s and does not have a set-aside designation.

AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to provide pharmaceuticals and medical supplies to military treatment programs and facilities worldwide. This specific delivery order is issued against that IDC to support the Department of Defense's medical and healthcare needs.

Generated 6/17/24, 9:42 AM